Viz.ai Adds PE Stratification | Liver Cancer Blood Test
Published: September 5, 2022
5th September 2022 – Contribution by Sanjay Parekh – Featured on ImagingWire.com
Viz.ai is So On-Trend – Signify Research recently forecast that AI leaders will increasingly expand into new clinical segments, enhance their current solutions, and leverage platform / marketplace strategies, as AI evolves from point solutions to comprehensive workflows. Those trends are certainly evident within Viz.ai’s recent PE strategy…
Click here to read the full article on the Imaging Wire website…
Share on LinkedIn